Skip to content
OpenCapital
Get started

Lear Corporation LEA Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss

Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss at other companies

Quanta Services logo
Quanta ServicesPWR
——

Other financials

Income statement

See full
Revenue$5.8B+4.7%
Gross profit$450.3M+25.4%
Operating income$255.0M+40.4%
Net income$172.3M+114%
EPS (diluted)$3.34+124%

Balance sheet

See full
Cash & equivalents$884.5M+13.0%
Total debt$3.5B+0.5%
Total equity$5.1B+9.2%
Total assets$15.5B+5.7%

Cash flow

See full
Operating cash flow$98.1M+177%
CapEx$124.6M+19.8%
Free cash flow-$26.5M+88.6%

Valuation

See full
Market cap$7B+29.8%
Enterprise value$9.64B+17.8%
P/E13.3×+2.0×
P/S0.3×+0.1×

Profitability

See full
Gross margin6.8%-0.2pp
Operating margin3.7%—
Net margin2.2%+0.2pp
FCF margin3.1%+1.0pp

Returns & leverage

See full
Return on equity10.8%+0.8pp
Debt / equity0.7×-0.1×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Lear Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount.

The official record: Lear Corporation’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss?
Lear Corporation (LEA) reported equity securities without readily determinable fair value - cumulative impairment loss of $19.6M in Q1 2026.
How has Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss changed year-over-year?
Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss increased by 15.3% year-over-year, from $17M to $19.6M.
What is the long-term trend for Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss?
Over 5 years (2020 to 2025), Lear Corporation's equity securities without readily determinable fair value - cumulative impairment loss has grown at a 16.8% compound annual growth rate (CAGR), from $9M to $19.6M.